[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.128.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 2, 1994

International Hepatology Communications

Author Affiliations

University of Southern California Los Angeles

 

T. Tsujii, editor-in-chief, G. Toda, associate editor-in-chief, bimonthly, $255, Amsterdam, the Netherlands, Elsevier, March 1993-.

JAMA. 1994;272(17):1386. doi:10.1001/jama.1994.03520170098048

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Given the prodigious output of research publication related to liver and liver disease, it is somewhat surprising that only a handful of journals devoted exclusively to hepatology have established themselves as standards. This in part explains the fact that of the approximately 15000 articles relating to liver and liver disease published in 1993 and indexed in MEDLINE, only about 1000 appeared in journals exclusively devoted to hepatology. The rest of the articles are widely diffused in journals of gastroenterology, pathology, cancer, immunology, virology, pharmacology, and experimental genetics. About 2000 of those liver-related articles in 1993 represented the work of Japanese investigators, regarded as world leaders in the area of hepatitis C and hepatocellular carcinoma research.

In spite of a distinguished international editorial board, Elsevier's new entry into this field, International Hepatology Communications, contains almost exclusively Japanese research, with only four articles from outside Japan among the 32 published in the

First Page Preview View Large
First page PDF preview
First page PDF preview
×